The U.S. District Court for the District of Connecticut granted preliminary approval of a plan to distribute settlement funds, the California Department of Justice announced on September 24, 2026; the plan was filed by California and a coalition of 47 other states and territories.
The DOJ says consumers who purchased a listed generic drug between May 2009 and December 2019 may be eligible for compensation; the deadline to submit a claim is March 8, 2027.
To check eligibility or file a claim the press release lists a toll-free number, an email address, and a website; call 1-866-290-0182, email info@AGGenericDrugs.com, or visit www.AGGenericDrugs.com.
The release reports prior settlements with Glenmark, Lannett, Bausch, Apotex, Heritage, and Heritage’s parent company Emcure totaling approximately $96.5 million; the coalition says the distribution plan aims to return millions of dollars from those funds to consumers harmed by elevated prices.
The DOJ describes a broader, ongoing multistate litigation that began in 2016 and has produced multiple complaints; the cases allege coordinated conduct by dozens of manufacturers and some executives and say the states’ evidence includes cooperating witnesses, millions of documents, and a large phone-record database.
The complaints, as described by the DOJ, allege defendants used phrases such as “fair share,” “playing nice in the sandbox,” and “responsible competitor” to discourage competition and raise prices; those are allegations in the states’ filings and have not been resolved in all cases.
Attorney General is quoted encouraging consumers to check eligibility; he said, “As a result of our efforts to hold generic drug manufacturers accountable for illegally conspiring to drive up prices, consumers may now be eligible to receive compensation.”
What remains unresolved: the distribution plan has preliminary approval only; some cases remain active and will proceed to trial, including a suit focused on 80 topical generics and other complaints filed this year alleging additional misconduct; preliminary approval does not decide liability in the pending cases.
State
Rob Bonta
Attorney General · Democrat
Named once in this story.
Portrait: Official portrait
Sources & methodology
This report was written from the primary materials below. Links open at the original publisher.
California Attorney GeneralSee something we should correct? Read our corrections policy.